Epilepsy.
Conditions
Interventions
Patients receive 250 mg single dose capsule (contained Anacyclus pyrethrum, Paeonia officinalis and Citrus aurantium varamara) for the three months.
Treatment - Drugs
Patients receive 250 mg single dose capsule (contained Anacyclus pyrethrum, Paeonia officinalis and Citrus aurantium varamara) for the three months
Sponsors
Vice-Chancellor for research affairs of Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
4 Years to 15 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: - Children aged between 4 and 15 years. - Drug resistant epilepsy (DRE) - Written informed consent from children parents Exclusion criteria: - Chronic diseases (such as diabetes mellitus, thyroid dysfunction, and heart, liver or kidney diseases) - Pseudoseizure - Neurodegenerative disease
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of seizure. Timepoint: At first and three mounths after intervention. Method of measurement: counting.;Intensity of seizure. Timepoint: At first and three mounths after intervention. Method of measurement: Asking from parents. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug reaction. Timepoint: At the end of the 3-month intervention period. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyedebrahim Mansoorinejad
Kerman university of medical sciences
Outcome results
None listed